Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: https://t.co/xwLWBZYRzq
@ASCO
Honored to be an elected member of the American Society for Clinical Investigation! @the_asci physician scientists are not a dying breed- we’re alive and kicking- and working on growing more! We will summit together! #thefutureisbright 💪
🚨We’re excited to spotlight a new publication from the FOCIS community—and that their research image is featured on the cover!
📝 Beta cell–targeted PD-1 agonist inhibits cell-mediated autoimmunity in pancreas tissue slices
https://t.co/qbas9JRr5E
Gervais, Trespidi, Ferrari, Rovida, Cobat, Zhang, Casanova, Borghesi et al. show that, in 13 European, Middle-Eastern, and American cohorts, pre-existing autoantibodies neutralizing type I IFNs are causal for WNV encephalitis in about 40% of patients. https://t.co/O1A79Q4OFx
@HsiehElena@FOCISimmunology@Focis_FCE Terrific!
FCEs contribute to advancing immunology through training and excellent courses.
Congratulations to the UC team and all FOCIS speakers from different centers.
Day 1 of the FOCIS 2026 Advanced Course is underway! Great turnout as we kick off this year’s course in a new location — Aurora, CO. Looking forward to a great week of learning and collaboration. 🧬
🎉 Congratulations to the 2026 Advanced Course Travel Award recipients!
Their hard work has been recognized, representing Colorado, the U.S., and institutions around the world. We’re excited to celebrate their achievements in Aurora, Colorado! 🌎👏
#FOCIS#FOCISAC2026
CAR-T cell therapy seems to have reset the immune system and eased severe symptoms in eight children and adolescents with autoimmune disorders
https://t.co/8VAkUXol6X
The FOCIS Advanced Course take's place next month - March 9–11, 2026, at the Benson Hotel & Faculty Club in Aurora, CO!
Lock in unbeatable hotel rates before they’re gone!
🔗 Register: https://t.co/CCpoTS8caI
Today is International Day of Women & Girls in Science! FOCIS celebrates the women shaping the future of immunology and our commitment to an equitable scientific community. 🧪🌍
Watch the video : https://t.co/XfKhWdvoAN
#ICYMI this open-access @ImmunoHorizons article: Interested in how to improve #reproducibility in your assays using human PBMCs? This study assessed the effects of different cell preparations on flow cytometry assays and uncovered differences in cell fitness. https://t.co/WGTjmXwzz3
🎄🎙️ Our latest podcast episode is live!
We sit down with Dr. Eric Vivier to talk about his journey into immunology and the groundbreaking work he’s doing today.
🎧 Listen: https://t.co/8l74EB84bl
🎥 Watch: https://t.co/EMeyw62DYR
📄 Recent paper: https://t.co/tEOqkSXnIQ
Exhibit at the FOCIS 2026 Annual Meeting!
Connect with 900+ attendees in San Francisco and increase your visibility with top researchers and clinicians in the field. Booths are now open.
https://t.co/HBu1nvYgIV
#FOCIS2026#immunology